Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5292
ANL
Adlai Nortye Ltd - American Depositary Shares
9.25 USD+0.11%-14.11%-8.14%+492.95%0 USD
5363
NVO
Novo Nordisk A/S
49.08 USD-0.41%+0.74%+9.77%-29.31%0 USD
6416
ADAP
Adaptimmune Therapeutics plc - American Depositary Shares
0.05 USD0.00%0.00%-61.54%-83.33%0 USD
6419
AADI
Aadi Bioscience Inc
2.05 USD0.00%0.00%-19.29%-27.30%0 USD

Frequently asked questions about Bristol-Myers Squibb Company Celegne Contingent Value Rights

What is the Bristol-Myers Squibb Company Celegne Contingent Value Rights stock price today?

The current price of Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG-RT) is 0.104. Over the past 24 hours, the stock has changed by -0.08%. Follow the CELG-RT chart for real-time price dynamics.

What is the stock ticker of Bristol-Myers Squibb Company Celegne Contingent Value Rights?

Bristol-Myers Squibb Company Celegne Contingent Value Rights trades under the ticker CELG-RT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bristol-Myers Squibb Company Celegne Contingent Value Rights stock going up?

CELG-RT has changed by +13.04% over the last week, -15.45% over the last month, and +228.08% over the last year. Review the chart to see whether the current move is part of a broader trend.

How can I buy Bristol-Myers Squibb Company Celegne Contingent Value Rights stock?

You can buy Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG-RT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bristol-Myers Squibb Company Celegne Contingent Value Rights stock?

Investing in Bristol-Myers Squibb Company Celegne Contingent Value Rights requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CELG-RT chart and related analysis on metatrader.com as part of your research.